Bertha Hidalgo

5.8k total citations
22 papers, 1.1k citations indexed

About

Bertha Hidalgo is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Bertha Hidalgo has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Virology and 5 papers in Infectious Diseases. Recurrent topics in Bertha Hidalgo's work include HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (4 papers) and HIV-related health complications and treatments (4 papers). Bertha Hidalgo is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (4 papers) and HIV-related health complications and treatments (4 papers). Bertha Hidalgo collaborates with scholars based in United States, Spain and Brazil. Bertha Hidalgo's co-authors include Melody S. Goodman, Claire W. Hallahan, Rebecca C. Arend, Donald J. Buchsbaum, Andrea Cherrington, Isabel C. Scarinci, Rajeev S. Samant, Angelina I. Londoño-Joshi, Yonghe Li and Anthony S. Fauci and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Diabetes.

In The Last Decade

Bertha Hidalgo

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bertha Hidalgo United States	14	314	294	222	137	110	22	1.1k
Jonathan Kagan United States	19	358 1.1×	431 1.5×	135 0.6×	236 1.7×	70 0.6×	44	1.4k
David J. Hunter United States	14	139 0.4×	104 0.4×	349 1.6×	163 1.2×	374 3.4×	29	1.3k
Cees Smit Netherlands	21	130 0.4×	55 0.2×	245 1.1×	129 0.9×	68 0.6×	50	1.9k
Janne E. Gaub United States	21	253 0.8×	226 0.8×	87 0.4×	204 1.5×	58 0.5×	61	1.5k
Zhangkai J. Cheng China	12	388 1.2×	42 0.1×	176 0.8×	96 0.7×	100 0.9×	61	1.1k
Jing Sun China	19	120 0.4×	71 0.2×	284 1.3×	197 1.4×	146 1.3×	107	1.5k
Julia Wu United States	16	800 2.5×	609 2.1×	83 0.4×	285 2.1×	47 0.4×	27	1.9k
Quentin Eichbaum United States	21	287 0.9×	179 0.6×	311 1.4×	239 1.7×	254 2.3×	82	2.1k
Jane Kelly United Kingdom	16	215 0.7×	33 0.1×	332 1.5×	278 2.0×	133 1.2×	33	1.1k
Elizabeth Secord United States	19	293 0.9×	41 0.1×	128 0.6×	234 1.7×	91 0.8×	87	1.6k

Countries citing papers authored by Bertha Hidalgo

Since Specialization

Citations

This map shows the geographic impact of Bertha Hidalgo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertha Hidalgo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertha Hidalgo more than expected).

Fields of papers citing papers by Bertha Hidalgo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertha Hidalgo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertha Hidalgo. The network helps show where Bertha Hidalgo may publish in the future.

Co-authorship network of co-authors of Bertha Hidalgo

This figure shows the co-authorship network connecting the top 25 collaborators of Bertha Hidalgo. A scholar is included among the top collaborators of Bertha Hidalgo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertha Hidalgo. Bertha Hidalgo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Suglia, Shakira F., Bertha Hidalgo, Andrea Baccarelli, et al.. (2025). Improving Cardiovascular Health Through the Consideration of Social Factors in Genetics and Genomics Research: A Scientific Statement From the American Heart Association. Circulation Cardiovascular Quality and Outcomes. 18(5). e000138–e000138. 3 indexed citations

Corlin, Laura, et al.. (2024). Synthesizing Subject-matter Expertise for Variable Selection in Causal Effect Estimation: A Case Study. Epidemiology. 35(5). 642–653. 2 indexed citations

Fox, Matthew P., et al.. (2021). Will Podcasting and Social Media Replace Journals and Traditional Science Communication? No, but.... American Journal of Epidemiology. 190(8). 1625–1631. 11 indexed citations

Liu, Yuwei, Caren E. Smith, Laurence D. Parnell, et al.. (2020). Salivary AMY1 Copy Number Variation Modifies Age-Related Type 2 Diabetes Risk. Clinical Chemistry. 66(5). 718–726. 9 indexed citations

Cardel, Michelle I., Emily J. Dhurandhar, Ceren Yarar‐Fisher, et al.. (2020). Turning Chutes into Ladders for Women Faculty: A Review and Roadmap for Equity in Academia. Journal of Women s Health. 29(5). 721–733. 71 indexed citations

Geng, Xin, Marguerite R. Irvin, Bertha Hidalgo, et al.. (2018). An exome-wide sequencing study of lipid response to high-fat meal and fenofibrate in Caucasians from the GOLDN cohort. Journal of Lipid Research. 59(4). 722–729. 6 indexed citations

Qi, Qibin, Adrienne M. Stilp, Tamar Sofer, et al.. (2017). Genetics of Type 2 Diabetes in U.S. Hispanic/Latino Individuals: Results From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Diabetes. 66(5). 1419–1425. 52 indexed citations

Bocanegra, Heike Thiel de, Olivia Carter‐Pokras, David Ingleby, et al.. (2017). Addressing refugee health through evidence-based policies: a case study. Annals of Epidemiology. 28(6). 411–419. 14 indexed citations

Das, Mithun, Marguerite R. Irvin, Jin Sha, et al.. (2015). Lipid changes due to fenofibrate treatment are not associated with changes in DNA methylation patterns in the GOLDN study. Frontiers in Genetics. 6. 304–304. 19 indexed citations

10.

Arend, Rebecca C., Somsundaram Chettiar, Nicholas Regan, et al.. (2015). Niclosamide Analogs for Treatment of Ovarian Cancer. International Journal of Gynecological Cancer. 25(8). 1377–1385. 20 indexed citations

11.

Londoño-Joshi, Angelina I., Rebecca C. Arend, Wenyan Lü, et al.. (2014). Effect of Niclosamide on Basal-like Breast Cancers. Molecular Cancer Therapeutics. 13(4). 800–811. 72 indexed citations

12.

Arend, Rebecca C., Angelina I. Londoño-Joshi, Rajeev S. Samant, et al.. (2014). Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer. Gynecologic Oncology. 134(1). 112–120. 140 indexed citations

13.

Martins, Maurício A., Myrna C. Bonaldo, Richard Rudersdorf, et al.. (2013). Immunogenicity of Seven New Recombinant Yellow Fever Viruses 17D Expressing Fragments of SIVmac239 Gag, Nef, and Vif in Indian Rhesus Macaques. PLoS ONE. 8(1). e54434–e54434. 10 indexed citations

14.

Hidalgo, Bertha. (2012). Validation of Self-Reported Measures in Health Disparities Research. Journal of Biometrics & Biostatistics. 3(7). 5 indexed citations

15.

Hidalgo, Bertha & Melody S. Goodman. (2012). Multivariate or Multivariable Regression?. American Journal of Public Health. 103(1). 39–40. 239 indexed citations

16.

Dybul, Mark, Marybeth Daucher, Kurt Hertogs, et al.. (2003). Long‐Cycle Structured Intermittent versus Continuous Highly Active Antiretroviral Therapy for the Treatment of Chronic Infection with Human Immunodeficiency Virus: Effects on Drug Toxicity and on Immunologic and Virologic Parameters. The Journal of Infectious Diseases. 188(3). 388–396. 62 indexed citations

17.

Dybul, Mark, Marybeth Daucher, Mark A. Jensen, et al.. (2003). Genetic Characterization of Rebounding Human Immunodeficiency Virus Type 1 in Plasma during Multiple Interruptions of Highly Active Antiretroviral Therapy. Journal of Virology. 77(5). 3229–3237. 35 indexed citations

18.

Dybul, Mark, Robert Bolan, David Condoluci, et al.. (2002). Evaluation of Initial CD4⁺T Cell Counts in Individuals with Newly Diagnosed Human Immunodeficiency Virus Infection, by Sex and Race, in Urban Settings. The Journal of Infectious Diseases. 185(12). 1818–1821. 60 indexed citations

19.

Dybul, Mark, Bertha Hidalgo, Tae‐Wook Chun, et al.. (2002). Pilot Study of the Effects of Intermittent Interleukin‐2 on Human Immunodeficiency Virus (HIV)–Specific Immune Responses in Patients Treated during Recently Acquired HIV Infection. The Journal of Infectious Diseases. 185(1). 61–8. 68 indexed citations

20.

Dybul, Mark, Tae‐Wook Chun, Christian Yoder, et al.. (2001). Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: Effects on virologic, immunologic, and toxicity parameters. Proceedings of the National Academy of Sciences. 98(26). 15161–15166. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact